Dr. Thomas Keller, D.O

NPI: 1073587515
Total Payments
$18,726
2024 Payments
$2,623
Companies
64
Transactions
1,336
Medicare Patients
8,562
Medicare Billing
$940,530

Payment Breakdown by Category

Food & Beverage$17,292 (92.3%)
Education$1,434 (7.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $17,292 1,325 92.3%
Education $1,434 11 7.7%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $3,176 273 $0 (2024)
PFIZER INC. $1,686 167 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,456 84 $0 (2024)
Summit Surgical Corp. $1,200 1 $0 (2022)
ABBVIE INC. $1,095 85 $0 (2024)
GlaxoSmithKline, LLC. $1,009 81 $0 (2024)
Lilly USA, LLC $998.78 65 $0 (2024)
Janssen Pharmaceuticals, Inc $769.76 69 $0 (2024)
Astellas Pharma US Inc $690.31 35 $0 (2024)
Amarin Pharma Inc. $574.12 63 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,623 150 Novo Nordisk Inc ($489.81)
2023 $2,572 166 Novo Nordisk Inc ($577.47)
2022 $3,575 177 Summit Surgical Corp. ($1,200)
2021 $2,576 189 AbbVie Inc. ($312.40)
2020 $1,962 171 Novo Nordisk Inc ($349.36)
2019 $1,819 160 Novo Nordisk Inc ($403.64)
2018 $1,850 164 Novo Nordisk Inc ($422.69)
2017 $1,749 159 Janssen Pharmaceuticals, Inc ($310.82)

All Payment Transactions

1,336 individual payment records from CMS Open Payments — Page 1 of 54

Date Company Product Nature Form Amount Type
12/18/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $20.37 General
Category: GASTROENTEROLOGY
12/18/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $19.27 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
12/12/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $18.19 General
Category: Diabetes
12/11/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $13.43 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/10/2024 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $19.66 General
Category: Insomnia
12/04/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $22.63 General
Category: Diabetes
12/02/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $19.63 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
11/26/2024 PFIZER INC. PAXLOVID (Drug) Food and Beverage In-kind items and services $18.44 General
Category: INFECTIOUS DISEASES
11/25/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $13.73 General
Category: Central Nervous System
11/22/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $18.61 General
Category: Diabetes
11/19/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $29.56 General
Category: PSYCHIATRY
11/18/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $20.50 General
Category: VACCINE
11/13/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $18.95 General
Category: Cardiovascular and Metabolism
11/11/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.78 General
Category: Central Nervous System
11/07/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $19.34 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
11/06/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.84 General
Category: NEUROSCIENCE
10/31/2024 GlaxoSmithKline, LLC. AREXVY (Drug) Food and Beverage In-kind items and services $14.30 General
Category: RESPIRATORY
10/30/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $18.15 General
Category: Diabetes
10/28/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $27.25 General
Category: Diabetes
10/23/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $14.61 General
Category: GASTROENTEROLOGY
10/16/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.64 General
Category: Respiratory
10/11/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $17.40 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/09/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $15.28 General
Category: PSYCHIATRY
10/07/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $25.23 General
Category: VACCINE
10/02/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $19.49 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 24 2,330 4,790 $403,082 $297,044
2022 25 2,007 4,598 $326,215 $233,427
2021 27 1,998 4,474 $310,808 $223,849
2020 29 2,227 4,088 $292,174 $186,210
Total Patients
8,562
Total Services
17,950
Medicare Billing
$940,530
Procedure Codes
105

All Medicare Procedures & Services

105 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 429 1,127 $107,065 $64,451 60.2%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 179 184 $55,200 $51,790 93.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 355 355 $46,150 $43,718 94.7%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 103 428 $36,380 $21,612 59.4%
J0897 Injection, denosumab, 1 mg Office 2023 13 1,260 $27,661 $21,328 77.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 173 245 $33,075 $20,515 62.0%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 206 207 $16,136 $15,682 97.2%
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 92 106 $19,080 $14,550 76.3%
G0008 Administration of influenza virus vaccine Office 2023 256 259 $6,734 $6,599 98.0%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 44 71 $8,165 $5,536 67.8%
99310 Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 30 45 $6,750 $5,271 78.1%
G0009 Administration of pneumococcal vaccine Office 2023 179 184 $4,784 $4,688 98.0%
99349 Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes Office 2023 39 49 $7,595 $4,122 54.3%
99350 Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes Office 2023 20 25 $5,500 $3,421 62.2%
99348 Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes Office 2023 36 60 $7,200 $3,104 43.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 17 17 $3,060 $2,081 68.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 17 17 $3,400 $2,078 61.1%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 13 13 $2,210 $2,055 93.0%
90756 Influenza vaccine, quadrivalent derived from cell cultures Office 2023 56 56 $1,896 $1,769 93.3%
99305 Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes Facility 2023 15 15 $2,175 $1,492 68.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 13 14 $910.00 $599.90 65.9%
96372 Injection of drug or substance under skin or into muscle Office 2023 16 24 $624.00 $257.04 41.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 17 17 $1,020 $186.15 18.3%
90471 Administration of vaccine Office 2023 12 12 $312.00 $136.53 43.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 422 1,086 $103,170 $62,512 60.6%

About Dr. Thomas Keller, D.O

Dr. Thomas Keller, D.O is a Internal Medicine healthcare provider based in Hanover, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073587515.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Keller, D.O has received a total of $18,726 in payments from pharmaceutical and medical device companies, with $2,623 received in 2024. These payments were reported across 1,336 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($17,292).

As a Medicare-enrolled provider, Keller has provided services to 8,562 Medicare beneficiaries, totaling 17,950 services with total Medicare billing of $940,530. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Hanover, PA
  • Active Since 02/13/2006
  • Last Updated 07/02/2010
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1073587515

Products in Payments

  • Ozempic (Drug) $1,458
  • FARXIGA (Drug) $662.42
  • Rybelsus (Drug) $638.40
  • ELIQUIS (Drug) $584.63
  • Vascepa (Drug) $574.12
  • VRAYLAR (Drug) $521.20
  • ENTRESTO (Drug) $493.89
  • TRELEGY ELLIPTA (Drug) $482.33
  • BREZTRI (Drug) $456.59
  • CHANTIX (Drug) $421.31
  • XARELTO (Drug) $382.28
  • INVOKANA (Drug) $381.46
  • UBRELVY (Drug) $372.46
  • JARDIANCE (Drug) $360.49
  • TRULICITY (Drug) $349.86
  • MOUNJARO (Drug) $278.63
  • SHINGRIX (Biological) $266.82
  • Victoza (Drug) $265.90
  • NURTEC ODT (Drug) $263.44
  • QULIPTA (Drug) $246.78

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Hanover